🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effectiveness of Desensitisation and Pain Neuroscience Education in Patients With Carpal Tunnel Syndrome With Nosiplastic Pain

RecruitingNAAges 18 Years - 65 YearsAllKutahya Health Sciences University
NCT06635213 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of our study was to determine the effectiveness of desensitisation and pain neuroscience education in a group of patients with mixed phenotype pain (neuropathic and nosiplastic).

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Being diagnosed with CTS * Being suitable for the nosiplastic pain phenotype * Being between the ages of 18-65 * Volunteering to participate in the study Exclusion Criteria: * Having systemic inflammatory disease * Having a disease that may cause polyneuropathy such as diabetes mellitus * Having a pacemaker * Having a disease affecting the central nervous system * Having cervical radiculopathy * History of previous operation or local steroid injection due to CTS * Hypersensitivity to heat and cold
💊

What it tests

  • Desensitisation
  • Pain neuroscience education
📍

Where

1 site
Kutahya Health Science University
Kütahya, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy